← All diseases
Lungs and airways
COPD
Would you like to receive a message when there is new research about COPD? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research on COPD is published. View what Premium costs.
Publications and studies (3222)
- Accuracy, Usefulness, and Impact Variability of ChatGPT-4 for COPD Medication Management: A Modified Delphi Study. (2026/08/04) ♡
- What factors predict severity of palliative care symptoms and concerns in COPD in South Africa? A cross-sectional study. (2026/08/04) ♡
- PM2.5 Exacerbates Airway Inflammation and Epithelial Barrier Disruption in Chronic Obstructive Pulmonary Disease Mice Through the RAGE-Dependent PERK/eIF2α/ATF4/CHOP Pathway. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Procalcitonin-Guided Strategies for Reducing Antibiotic Use in CAP, HAP, VAP, and COPD: Insights From a Systematic Review and Meta-Analysis. (2026/08/04) ♡
- Identifying potential core genes for chronic obstructive pulmonary disease associated with cocaine exposure via integrated bioinformatics and network toxicology. (2026/08/04) ♡
- Prevalence and Risk Factors of Sleep Disordered Breathing in School-Aged Children with Bronchopulmonary Dysplasia. (2026/08/04) ♡
- Xiaoqinglong decoction suppresses M1 macrophage polarization in COPD via the MET/AKT/HK2 axis: An integrated multi-omics analysis. (2026/08/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Low sRAGE Level is Associated with Increased Future Exacerbation Risk in Mild-to-Moderate COPD and Patients with Chronic Bronchitis Symptoms. (2026/08/03) ♡
- Sepsis risk in patients with COPD and type 2 diabetes mellitus: influence of emerging antihyperglycemic therapies. (2026/08/02) ♡
- Clinical Outcome and Safety of Procedural Sedation and Analgesia Performed by Interventional Radiologists in Patients Undergoing Local Tumor Ablation of the Liver. (2026/08/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Chronic obstructive pulmonary disease (COPD), advanced age, and comorbidities]. (2026/08/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Electroacupuncture mitigates lung injury, increases endogenous antioxidant levels and modulates Nrf2 signaling in a rat model of chronic obstructive pulmonary disease. (2026/08/01) ♡
- Aristolochic acid and the risk of female lung cancer: Population-based case-control study in Taiwan. (2026/08/01) ♡
- Association between phenotypic age acceleration and mortality in patients with chronic obstructive pulmonary disease. (2026/08/01) ♡
- Association of better cardiovascular health defined by life's essential 8 with lower incidences of lung diseases. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tryptophan metabolism as a key integrator within the gut-lung-brain axis: Mechanistic insights and nutritional therapeutic strategies for inflammatory and neuropsychiatric disorders. (2026/08/01) ♡
- The dominant role of geriatrics vulnerabilities and comorbidities in readmissions after colorectal surgery: Shifting from "nonmodifiable" to "actionable" risk. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Nutritional anemia is associated with increased risk of severe COPD exacerbations: a prospective cohort study. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. "More Kairos, Less Chronos": Sleep, circadian rhythms and the path to cardiovascular, neurological and metabolic protection. (2026/08/01) ♡
- Emphysema and airway disease synergistically impair exercise tolerance in smokers: A CT-based study. (2026/08/01) ♡
- Haemodynamic responses to small muscle mass exercise before and after lung transplantation in end-stage chronic obstructive pulmonary disease. (2026/08/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Before Corticosteroids for Allergic Bronchopulmonary Aspergillosis. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Particle engineering, aerosol physics, and pulmonary deposition of single-inhaler triple ICS/LABA/LAMA therapies in obstructive airway diseases. (2026/08/01) ♡
- miR-766-5p Attenuates Cigarette Smoke-Induced COPD by Targeting MAPK1. (2026/08/01) ♡
- Role of α-SMA, NOX4, Fibronectin, and HIF-1α in Pulmonary Microvascular Remodeling in COPD Patients Without Pulmonary Arterial Hypertension. (2026/08/01) ♡
- The association between blood eosinophil count and clinical outcomes during inhaled corticosteroid/long-acting β2-agonist treatment in stable-phase chronic obstructive pulmonary disease: A retrospective cohort analysis. (2026/07/31) ♡
- Integrative multi-omics and machine learning identify CHRNA1 putative circadian-immune hub in COPD. (2026/07/31) ♡
- Design and development of a disease-agnostic remote patient monitoring typology and associated tools. (2026/07/31) ♡
- Latent profile analysis of breathlessness catastrophizing in patients with chronic obstructive pulmonary disease. (2026/07/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success. (2026/07/31) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Co-managing the double burden: strategies for simultaneously tackling infectious and non-communicable diseases. (2026/07/31) ♡
- Exposure to Airborne Particulate Matter in Regional Environments of Bangladesh and Its Effects on Respiratory Health: A Narrative Review. (2026/07/31) ♡
- Longitudinal Outcomes and Prognostic Risk of Normalized Airflow Obstruction in a Korean General Population Cohort. (2026/07/31) ♡
- Integrated network pharmacology and molecular docking based insights into transient receptor potential melastatin3 regulatory mechanism in COPD. (2026/07/31) ♡
- Exploring the toxic effects of Kusnezoff Monkshood Root on respiratory diseases and analyzing its mechanism based on network toxicology and molecular docking technique: An in silico study. (2026/07/31) ♡
- Associations among probiotic/prebiotic consumption, depression and chronic obstructive pulmonary disease: A cross-sectional study. (2026/07/31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 28-Day Mortality and Prognostic Factors in COPD Patients with Sepsis: A Retrospective Study Using eICU-CRD Database. (2026/07/30) ♡
- COPD and Dysphagia, a 2-Year Follow-up of the Prospective TIE-Cohort Study. (2026/07/28) ♡
- Dynamic Changes in Airway Microbiota and Immune Homeostasis in Patients With COPD and the Implications for Nursing Management. (2026/07/28) ♡
- Integrative machine learning and single-cell analysis identifies nicotine-related diagnostic genes and myeloid remodeling in COPD. (2026/07/27) ♡
- Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program. (2026/07/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Factors Influencing Team-Based Vaccination Collaboration in Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Survey of Primary Care Teams in Beijing, China. (2026/07/27) ♡
- Routine Blood Biomarkers and Lung Function in Asthma-COPD Overlap versus Asthma-Only Among Hospitalized Asthma Patients: A Retrospective Cross-Sectional Study. (2026/07/27) ♡
- Identifying the Challenges in Self-Management and Preferences for Digital Health Technologies Use Among COPD Patients Based on the CeHRes Roadmap: A Formative Qualitative Study. (2026/07/27) ♡
- Association Between Composite Dietary Antioxidant Index and Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Evidence From a Large Cohort in the UK Biobank. (2026/07/26) ♡
- Qingfei Tongluo Formula attenuates COPD-associated ferroptosis by restoring arachidonic acid metabolic balance via dual inhibition of prostaglandin-endoperoxide synthase 2 and soluble epoxide hydrolase 2. (2026/07/25) ♡
- Subungual hyperkeratosis as a diagnostic cue in crusted scabies. (2026/07/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The airway epithelial-immune axis: mechanisms and therapeutic implications. (2026/07/24) ♡
- Association between intensity and type of physical activity and lung function in patients with COPD: a population-based study. (2026/07/24) ♡
- Correlation analysis of serum galectin-3 combined with Th1/Th2-related cytokines and severe anxiety and depression symptoms in patients with chronic obstructive pulmonary disease. (2026/07/24) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.